Controlling endemic cholera with oral vaccines

PLoS Medicine

Volumn 4, Issue 11, 2007, Pages 1776-1783

  Longini Jr , Ira M ^a,b   Nizam, Azhar ^c   Ali, Mohammad ^d   Yunus, Mohammad ^e   Shenvi, Neeta ^c   Clemens, John D ^d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c EMORY UNIVERSITY   (United States)

^d International Vaccine Institute   (South Korea)

^e INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; PLACEBO; VACCINE;

ARTICLE; BACTERIAL TRANSMISSION; CHOLERA; CONTROLLED STUDY; DISEASE CONTROL; ENDEMIC DISEASE; HUMAN; INCIDENCE; INNATE IMMUNITY; STOCHASTIC MODEL; ADOLESCENT; ADULT; BANGLADESH; CHILD; CLINICAL TRIAL (TOPIC); EPIDEMIC; IMMUNOLOGY; INFANT; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; STATISTICAL MODEL; STATISTICS; THEORETICAL MODEL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BANGLADESH; CHILD; CHILD, PRESCHOOL; CHOLERA; CHOLERA VACCINES; CLINICAL TRIALS AS TOPIC; DISEASE OUTBREAKS; HUMANS; INFANT; MODELS, STATISTICAL; MODELS, THEORETICAL; STOCHASTIC PROCESSES; VACCINES;

EID: 36849028632     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040336     Document Type: Article

References (19)

1. WHO (2006) Cholera, 2005. Wkly Epidemiol Rec 81: 297-308.
2. Clemens JD, Sack DA, Harris JR, van Loon F, Chakraborty J, et al. (1990) Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335: 270-273.
3. Durham LK, Longini IM, Halloran ME, Clemens JD, Nizam A, et al. (1998) Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines. Am J Epidemiol 147: 948-959.
4. Thiem VD, Hossain MM, Son ND, Hoa NT, Rao MR, et al. (2003) Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam. J Health Popul Nutr 21: 304-308.
5. WHO (2005) Cholera, 2004. Wkly Epidemiol Rec 80: 261-268.
6. Sack DA (2003) When should cholera vaccine be used in cholera-endemic areas? J Health Popul Nutr 21: 299-303.
7. Ali M, Emch M, von Seidlein L, Yunus M, Sack DA, et al. (2005) Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 366: 44-49.
8. Barua D, Greenough WB (1002) Cholera. New York: Plenum.
9. Heyman DLeditor (2004) Control of communicable diseases manual. 18th Ed. Washington (D. C.): American Public Health Association.
10. Sack DA, Sack RB, Nair GB, Siddique AK (2004) Cholera. Lancet 363: 223-233.
11. Clemens JD, Sack DA, Rao MR, Chakraborty J, Kay B, et al. (2003) The design and analysis of cholera vaccine trials: recent lessons from Bangladesh. Int J Epidemiol 22: 724-730.
12. Longini IM, Yunus M, Zaman Z, Siddique AK, Sack RB, et al. (2002) Epidemic and endemic cholera trends over thirty-three years in Bangladesh. J Infec Dis 186: 246-251.
13. Hartley DM, Morris JG, Smith DL (2006) Hyperinfectivity: a critical element in the ability of V. cholerae to cause epidemics? PloS Med 3: e7. doi:10.1371/journal.pmed.0030007
14. Huq A, Sack RB, Nizam A, Longini IM, Nair GB, et al. (2005) Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh. Appl Environ Microbiol 17: 4645-4654.
15. Halloran ME, Longini IM, Struchiner CJ (1999) Design and interpretation of vaccine field studies. Epidemiol Rev 21: 73-88.
16. Koelle K, Rodo X, Pascual M, Yunus M, Mostafa G (2005) Refractory periods and climate forcing in cholera dynamics. Nature 436: 696-700.
17. Koelle K, Pascual M (2004) Disentangling extrinsic from intrinsic factors in disease dynamics: a nonlinear time series approach with an application to cholera. Am Naturalist 163: 901-913.
18. Legros D, Paquet C, Perea W, Marty I, Mugisha MK, et al. (1999) Mass vaccination with a two dose oral cholera vaccine in a refugee camp. Bull WHO 77: 837-842.
19. Cavallier P, Lucas M, Ducooud V, McChesney M, Anpuer S, et al. (2005) Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique. Vaccine 24: 4890-4895.